The recently announced decision of the United States District Court in Manhattan, UMG v. Escape Media Group (Grooveshark), serves to further elucidate the terms on which
On October 23rd and 24th, inventors, law students, lawyers, patent agents, patent portfolio managers, policy analysts, Canadian Intellectual Property Office’s (CIPO) patent examiners and other
On September 23, Canada’s Competition Bureau (“the Bureau”) announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada’s competition law framework. The
IP Osgoode would like to thank everyone who attended Professor Graeme B. Dinwoodie‘s lecture, titled “Territoriality of Trademarks in a Post-National Era,” on September 18,
Knockoffs run rampant in the retail and fashion industries. For those of us that are fashion-forward but not looking to incur debilitating debt, we resign
Originating back in 2006, the litigation between Pfizer and Apotex over Pfizer’s blockbuster drug, Lipitor, has been long and arduous. With many twists and turns
